Back to UBS Group AG UBS Group AG

ELAN

Showing 8 of 30 quarters

Position history for UBS Group AGUBS Group AG's holdings in Elanco Animal Health Incorporated

Yes. Ubs holds 9,910,822 shares of ELAN (Elanco Animal Health), worth $243.9M, as of its Q2 2026 13F filing. It increased the position by 1,338,765 shares (+15.6%) from Q1 2026. Ubs has held ELAN in every 13F on record since Q1 2019, 30 quarterly filings.

Current Value

$243.9M

Current Shares

9.9M

Total Value Change

+$216.4M

Total Shares Change

+8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
9.9M
+15.6%
$243.9M0.0%$24.61
35
2026-Q1
Decreased
8.6M
-1.2%
$205.1M0.0%$23.93
0
2025-Q4
Decreased
8.7M
-47.3%
$196.3M0.0%$22.63
0
2025-Q3
Increased
16.5M
+56.7%
$331.7M0.1%$20.14
44
2025-Q2
Increased
10.5M
+136.6%
$150M0.0%$14.28
49
2025-Q1
Increased
4.4M
+6.6%
$46.6M0.0%$10.50
31
2024-Q4
Increased
4.2M
+122.6%
$50.4M0.0%$12.11
47
2024-Q3
Decreased
1.9M
-2.1%
$27.5M0.0%$14.32
0

Other major holders of ELAN: Dodge & Cox, T. Rowe Price Associates, Inc.

Optional analytics helps us improve. How it’s used